The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 13, 2018

Filed:

May. 04, 2012
Applicants:

Natasha Barascuk Michaelsen, Kobenhavn S, DK;

Federica Genovese, Kobenhavn O, DK;

Morten Karsdal, Kobenhavn O, DK;

Diana Julie Leeming, Espergaerde, DK;

Inventors:

Natasha Barascuk Michaelsen, Kobenhavn S, DK;

Federica Genovese, Kobenhavn O, DK;

Morten Karsdal, Kobenhavn O, DK;

Diana Julie Leeming, Espergaerde, DK;

Assignee:

Nordic Biociences A/S, Herlev, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 31/00 (2006.01); G01N 33/68 (2006.01); C07K 16/18 (2006.01); C12Q 1/37 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); C07K 14/4725 (2013.01); C07K 16/18 (2013.01); C12Q 1/37 (2013.01); G01N 33/6878 (2013.01); C07K 2317/34 (2013.01); G01N 2800/32 (2013.01); G01N 2800/323 (2013.01);
Abstract

A method of bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage of mimecan, a protein of an atherosclerotic plaque, by a proteinase is provided. In the method a sample, such as urine or serum, is contacted with an antibody reactive with the neo-epitope and the level of binding of the antibody to peptide fragments in the sample is determined. The assay is predictive of risk of cardiovascular disease events.


Find Patent Forward Citations

Loading…